Comparison
21q22 11q22 12 Microdeletion Syndrome C5192593 vs 15q11q13 Microduplication Syndrome C2675336
Clinical comparison between 21q22 11q22 12 Microdeletion Syndrome and 15q11q13 Microduplication Syndrome for differential diagnosis and treatment planning.
21q22 11q22 12 Microdeletion Syndrome C5192593
A rare genetic condition involving deletion of a specific region on chromosome 21. It may cause developmental delay, intellectual disability, and distinctive facial features. Management focuses on developmental support and medical monitoring.
15q11q13 Microduplication Syndrome C2675336
A genetic disorder involving duplication of material from the chromosome 15 region linked to Prader-Willi and Angelman syndromes. Features may include developmental delays, learning difficulties, and sometimes autism spectrum traits. Supportive therapies help manage symptoms.
6 comparison axes
Onset
21q22 11q22 12 Microdeletion Syndrome C5192593
0-0
15q11q13 Microduplication Syndrome C2675336
0-3
Onset patterns differ
Severity
21q22 11q22 12 Microdeletion Syndrome C5192593
severe
15q11q13 Microduplication Syndrome C2675336
moderate
Different severity levels
Chronic
21q22 11q22 12 Microdeletion Syndrome C5192593
Chronic
15q11q13 Microduplication Syndrome C2675336
Chronic
Differing course
Communicable
21q22 11q22 12 Microdeletion Syndrome C5192593
No
15q11q13 Microduplication Syndrome C2675336
No
Different transmission
Body System
21q22 11q22 12 Microdeletion Syndrome C5192593
congenital
15q11q13 Microduplication Syndrome C2675336
congenital
Same/different system
Category
21q22 11q22 12 Microdeletion Syndrome C5192593
rare-disease
15q11q13 Microduplication Syndrome C2675336
genetic
Different category
Bottom line
21q22-11q22-12-microdeletion-syndrome-C5192593 and 15q11q13-microduplication-syndrome-C2675336 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 15q11q13 Microduplication Syndrome C2675336 | Discriminating power |
|---|---|---|---|
| Developmental delay | Delay with possible intellectual disability is described. | Delays and learning difficulties are described; autism traits may occur. | Moderate |
| Facial appearance | Distinctive facial features are reported, but not specified here. | No characteristic facial pattern is established by the supplied data. | Low |
| Age at recognition | Supplied onset is at birth. | Supplied onset spans birth to about age 3 years. | Moderate |
When to favor each condition
Choose 21q22 11q22 12 Microdeletion Syndrome C5192593 when
A deletion involving 21q22.11-q22.12 is confirmed
The chromosomal result, not symptoms alone, defines this condition.
High
Severe congenital developmental concerns from birth
This fits the supplied severity and onset, but is not diagnostic.
Low
Reported distinctive facial features with delay
May support clinical suspicion pending genetic confirmation.
Low
Choose 15q11q13 Microduplication Syndrome C2675336 when
A duplication of 15q11-q13 is confirmed
Region and copy-number change distinguish it from a chromosome 21 deletion.
High
Learning difficulty or autism traits emerge in early childhood
Consistent with the description, but many other causes exist.
Low
Moderate rather than severe overall course
Matches the supplied severity label without proving the diagnosis.
Low
How key tests differ
| Test | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 15q11q13 Microduplication Syndrome C2675336 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Deletion in the stated chromosome 21 region. | Duplication in 15q11-q13. | Copy number, chromosome, and breakpoints require laboratory confirmation. |
| Karyotype | May miss a small deletion. | May miss a small duplication. | A normal karyotype does not exclude either condition. |
| Developmental assessment | May show substantial developmental impairment. | May show learning or social-communication differences. | Assessment guides support but cannot identify the chromosomal change. |
Prognosis comparison
21q22 11q22 12 Microdeletion Syndrome C5192593
- Outcome
- A chronic, potentially severe course is described; individual outcome is not established.
- Factors
- Deletion details, associated findings, and access to developmental support may matter.
15q11q13 Microduplication Syndrome C2675336
- Outcome
- A chronic, generally moderate course is described, with wide individual variation.
- Factors
- Duplication details, learning or autism-related needs, and support services may matter.
Time frame: Lifelong, with needs changing from infancy through adulthood.
No reliable mortality or universal outcome can be inferred from the supplied data.
Complications comparison
| Complication | Presentation |
|---|---|
| Learning and development | Intellectual disability is possible. Learning difficulty and sometimes autism traits are described. Range and severity are not established by these source data. |
| Medical complications | Specific organ complications are not established here. Specific organ complications are not established here. Monitoring should follow each person’s confirmed findings. |
| Inheritance implications | Not established from the supplied description. Not established from the supplied description. Genetic counseling is needed before recurrence estimates are given. |
Patient education highlights
- HighDiagnosis
Only a confirmed genetic test can distinguish these conditions; symptoms overlap with many disorders.
- HighCare
Management is supportive, including developmental services and individualized medical monitoring. No dose or cure is established here.
- MediumTransmission
Neither condition is communicable. Family recurrence risk requires genetics review.